Xin Lang Cai Jing·2025-08-21 02:22Core Viewpoint - The market is experiencing a rotation from high valuation sectors to reasonably valued sectors, with a notable rebound in core assets in the medical innovation space [1] Group 1: Market Performance - On August 21, the market showed a "high-low cut" trend, with medical devices, traditional Chinese medicine, and vaccines leading in gains [1] - The Medical Innovation ETF (516820.SH) rose by 1.28%, with key stocks such as Pizhou Pharmaceutical (600436) up 4.84%, Mindray Medical (300760) up 3.73%, and Yuyue Medical (002223) up 2.43% [1] Group 2: Investment Opportunities - Funds are shifting towards undervalued sectors, with core assets in medical innovation gradually rebounding [1] - The top ten component stocks in the Medical Innovation ETF are mostly valued below the historical 20th percentile, indicating a significant safety margin [1] - Investors who missed the first half of the medical sector rally can position themselves in the Medical Innovation ETF (516820) to capitalize on the recovery [1]